الرسائل الموجهة للمختصين الصحيين

Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia.

Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia.

Updated recommendations to minimize the risk of drug-induced liver injury (DILI).

Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia

Updated recommendations to minimize the risk of drug-induced liver injury (DILI)

HALDOL® 5mg/ml (HALOPERIDOL) solution for injection: Incorrect information on route of administration on outer carton

Esbriet (pirfenidone): Important safety update and new recommendations to prevent Drug-Induced Liver Injury (DILI)

Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence.

Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence.

Notification of typographical error in the Revlimid® (Lenalidomide) Hard Capsules Patient Information Leaflet (PIL)